Vpriv worldwide launch?

When and where was Vpriv first launched worldwide?

VPRIV (vocloro/velaglucerase alfa, a treatment for Gaucher disease) has had launches that differed by country and regulator. The exact “worldwide launch” date depends on which jurisdiction you mean (for example, first approval by regulators vs. market entry in each country).

What’s the practical way to confirm Vpriv’s launch date in each country?

For a “worldwide launch” answer, the most reliable approach is to check each country’s regulator approval/marketing authorization date, then match it to when the product first became commercially available. Country-specific launch timing can vary due to reimbursement decisions, distribution readiness, and label updates.

Did Vpriv launch simultaneously across regions?

No. Biopharmaceutical launches commonly roll out in phases. Even if a product is approved on a specific timeline, “launch” in the real market can lag because of contracting, pricing, and local manufacturing or distribution setup.

Which type of “launch” do people usually mean?

Searches for “worldwide launch” usually mean one of these:
- First regulatory approval date in the first country
- First approval in major regions (e.g., US/EU/Japan)
- First time it was sold widely (pricing/reimbursement-driven market access)
- Availability by formulation and pack size (sometimes differs by country)

If you tell me which meaning you need (first approval vs. market availability) and which regions you care about (US, EU, UK, Canada, Japan, etc.), I can produce a more precise timeline using the relevant launch/authorization dates.

What do you need from me to make this exact?

Reply with:
1) Do you mean first regulatory approval or first market sale?
2) Which countries/regions should be included (or “top markets only”)?
3) Do you want dates only, or also approval type (initial vs. label expansion)?